According to a new market research report the overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.
Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. Presently, many companies are developing various infusion devices capable of being integrated with alarm devices, monitoring devices, and data exchange systems. This integration helps prevent an overdose or reduced dose of infusion solutions to patients and minimizes dosing errors.
Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=78345313
Increasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this market.
Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer significant advantages over manual fluid administration, including the ability to deliver fluids in very small volumes and at precisely programmed rates or automated intervals. These devices are also used for blood transfusion.
The IV equipment market has been segmented, on the basis of product into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and other IV equipment. The market for securement devices is expected to grow at the highest CAGR between 2017 and 2022. Increasing adoption of central venous catheter securement devices and peripheral IV catheter securement devices during IV therapy owing to the advantages such as water resistant and can be repositioned upon initial application.
Browse 102 market data tables and 38 figures spread through 166 pages and in-depth TOC on “IV Equipment Market”
http://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html
North America dominated the IV Equipment Market in 2016
In 2016, North America accounted for the largest share of the global Intravenous (IV) therapy devices Market, followed by Europe, Asia-Pacific, and RoW. This growth can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, the presence of a well-established healthcare industry, growing demand for advanced medical treatments, the presence of major players, and increasing government healthcare expenditure.
Some key players mentioned in the research report are:
Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter Interanl Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), C. R. Bard, Inc. (U.S.), Terumo Corporation (Japan), Moog, Inc. (U.S.), and AngioDynamics, Inc. (U.S.). These players adopted both organic as well as inorganic strategies such as product launches and enhancements, collaborations and agreements, acquisitions and grant to sustain in this market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
[email protected]
This integration helps prevent an overdose or reduced dose of infusion solutions to patients and minimizes dosing errors.
[166 Pages Report] The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.The global burden of chronic diseases such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes is increasing rapidly.
According to the World Health Organization (WHO) 2015, chronic diseases accounted for approximately 60% of the total reported deaths in the world.
The proportion of the burden of chronic diseases (chronic non-communicable diseases) is expected to increase to 57% by 2020 from 46% in 2001.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteIncreasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this marketGet a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein.
This integration helps prevent an overdose or reduced dose of infusion solutions to patients and minimizes dosing errors.
[166 Pages Report] The overall IV equipment market is expected to grow from USD 10.07 billion in 2017 to USD 13.64 billion by 2022, at a CAGR of 6.2% from 2017 to 2022.The global burden of chronic diseases such as heart disease, stroke, cancer, chronic respiratory diseases, and diabetes is increasing rapidly.
According to the World Health Organization (WHO) 2015, chronic diseases accounted for approximately 60% of the total reported deaths in the world.
The proportion of the burden of chronic diseases (chronic non-communicable diseases) is expected to increase to 57% by 2020 from 46% in 2001.Market Dynamics1.
Low Prices of Reprocessed Medical Devices2.
Pressure to Reduce Volume of Regulated Medical WasteIncreasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this marketGet a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein.
Rising prevalence of chronic diseases around the globe, increased focus of technological advancements involved in the manufacturing of medical devices, and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of intravenous (IV) equipment market.
The intravenous (IV) equipment is used to give medicine, rectification of electrolyte imbalances, transfusing blood, maintain blood pressure and give other fluids to the body of the patients.
The intravenous (IV) equipment is the fastest method of giving liquid and solutions to the body.
Download sample report @ https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-iv-equipment-market This intravenous (IV) equipment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
To gain more info on intravenous (IV) equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.Get Details TOC : https://www.databridgemarketresearch.com/toc/?dbmr=global-iv-equipment-market The major players covered in the intravenous (IV) equipment market report are B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein, Inc., Smiths Medical, Baxter., Ascor S.A., Moog Inc., AngioDynamics., ICU Medical, Inc., Fresenius SE & Co. KGaA, Animas LLC, arcomed ag, truxtonpharma.com, International WIN, LTD., Lars medicare Pvt Ltd. and The Metrix Company.
among other domestic and global players.
